Lexology November 25, 2024
McGuireWoods LLP

Click here to listen to the audio.

As the pharma services sector grows, regulators at the Department of Justice and Food and Drug Administration are putting everything from clinical trials to site management under the microscope.

McGuireWoods partner Clint Narver speaks from experience: He joined the firm after serving in leadership roles at both agencies. With host Geoff Cockrell, Clint helps industry stakeholders understand regulators’ enforcement priorities. He covers the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Govt Agencies, Investments, Pharma, Pharma / Biotech, Regulations, Trends
National Health Expenditures In 2023: Faster Growth As Insurance Coverage And Utilization Increased
Startup SiteOne Secures $100M to Forge Ahead With Novel Non-Opioid Pain Meds
Health care package winners and losers
A New Weight Loss Drug With No Side Effects? Yes…So Far
The AI Advantage: Reimagining the Future of Drug Development

Share This Article